Home | Cuprous Pharmaceuticals (CPI) | Nanomedicines | Vancouver
Description
Cuprous Pharmaceuticals provides partners with technologies and expertise in developing small molecule nanomedicines addressing solubility issues, reducing Cmax related toxicities, and improving therapeutic activity for pre-clinical and clinical use.